Advertisement

Canadian regulators give InSightec a nod of approval for the ExAblate system to treat benign uterine tumors and painful metastatic bone tumors.

Canada green-lights InSightec's ablation system

Canadian healthcare regulators approved InSightec's ExAblate ultrasound system, clearing the device for use against 2 different diseases. Health Canada granted ExAblate indication to break up benign uterine tumors and to alleviate painful symptoms of metastatic bone tumors.

The Tirat Carmel, Israel-based company specializes in ultrasound ablation technology. InSightec's ExAblate uses a highly focused beam, guided by an MRI, to break up tissue. The tumor-busting procedure uses non-iodizing radiation and alleviates symptoms without surgical removal.

Advertisement
Advertisement